Skip to main content

Advertisement

SpringerLink
Log in

Rheumatoid arthritis and cardiovascular disease

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

An increased risk of cardiovascular events and subclinical atherosclerosis in patients with rheumatoid arthritis (RA) has been attributed to the inflammatory milieu associated with this chronic autoimmune disease and possibly to the independent effects of RA medications on risk. This review provides an update on the most recent epidemiologic studies documenting this relationship and noteworthy publications examining RA-related factors that could influence the role of traditional cardiovascular risk factors and expression of atherosclerotic disease in patients with RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, et al.: HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007, 57:125–132.

    Article  PubMed  CAS  Google Scholar 

  2. Farragher TM, Goodson NJ, Naseem H, et al.: Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum 2008, 58:359–369.

    Article  PubMed  Google Scholar 

  3. Turesson C, McClelland RL, Christianson TJ, Matteson EL: Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 2007, 66:70–75.

    Article  PubMed  CAS  Google Scholar 

  4. Banerjee S, Compton AP, Hooker RS, et al.: Cardiovascular outcomes in male veterans with rheumatoid arthritis. Am J Cardiol 2008, 101:1201–1205.

    Article  PubMed  Google Scholar 

  5. Sodergren A, Stegmayr B, Lundberg V, et al.: Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis. Ann Rheum Dis 2007, 66:263–266.

    Article  PubMed  Google Scholar 

  6. Aubry M-C, Maradit-Kremers H, Reinalda MS, et al.: Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 2007, 34:937–942.

    PubMed  CAS  Google Scholar 

  7. Roman MJ, Moeller E, Davis A, et al.: Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006, 144:249–256.

    PubMed  Google Scholar 

  8. del Rincon I, O’Leary DH, Freeman GL, Escalante A: Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 2007, 195:354–360.

    Article  PubMed  Google Scholar 

  9. Kao AH, Wasko MC, Krishnaswami S, et al.: C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis. Am J Cardiol 2008 (in press).

  10. Ciftci O, Yilmaz S, Topcu S, et al.: Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis. Atherosclerosis 2008, 198:332–337.

    Article  PubMed  CAS  Google Scholar 

  11. Avalos I, Chung CP, Oeser A, et al.: Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis. J Rheumatol 2007, 34:2388–2394.

    PubMed  Google Scholar 

  12. Hannawi S, Haluska B, Marwick TH, Thomas R: Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther 2007, 9:R116–R124.

    Article  PubMed  Google Scholar 

  13. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, et al.: HLADRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 2003, 114:647–652.

    Article  PubMed  CAS  Google Scholar 

  14. Pahor A, Hojs R, Gorenjak M, Rozman B: Accelerated atherosclerosis in pre-menopausal female patients with rheumatoid arthritis. Rheumatol Int 2006, 27:119–123.

    Article  PubMed  CAS  Google Scholar 

  15. Wallberg-Jonsson S, Caidahl K, Klintland N, et al.: Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis. Scand J Rheumatol 2008, 37:1–5.

    Article  PubMed  CAS  Google Scholar 

  16. Kerekes G, Szekanecz Z, Der H, et al.: Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: A multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 2008, 35:398–406.

    PubMed  CAS  Google Scholar 

  17. Herbrig K, Haensel S, Oelschlaegel U, et al.: Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann Rheum Dis 2006, 65:157–163.

    Article  PubMed  CAS  Google Scholar 

  18. Gonzalez A, Kremers HM, Crowson CS, et al.: Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients. Ann Rheum 2008, 67:56–69.

    Google Scholar 

  19. Chung CP, Oeser A, Avalos I, et al.: Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther 2006, 8:R186–R192.

    Article  PubMed  Google Scholar 

  20. Chung CP, Oeser A, Solus JF, et al.: Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008, 198:756–763.

    Article  Google Scholar 

  21. Dessein PH, Tobias M, Veller MG: Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol 2006, 33:2425–2432.

    PubMed  Google Scholar 

  22. McMahon M, Grossman J, FitzGerald J, et al.: Proin-flammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006, 54:2541–2549.

    Article  PubMed  CAS  Google Scholar 

  23. Cesur M, Ozbalkan Z, Temel MA, Karaastan Y: Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis. Clin Rheumatol 2007, 26:355–361.

    Article  PubMed  Google Scholar 

  24. Georgiadis AN, Papavasilious EC, Lourida ES, et al.: Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective, controlled study. Arthritis Res Ther 2006, 8:R82–R88.

    Article  PubMed  Google Scholar 

  25. Lourida ES, Georgiadis AN, Papavasilious EC, et al.: Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2. Arthritis Res Ther 2007, 9:R19–R26.

    Article  PubMed  Google Scholar 

  26. Charles-Schoeman C, Khanna D, Furst DE, et al.: Effects of high-dose atorvastatin on anti-inflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: A pilot study. J Rheumatol 2007, 34:1459–1464.

    PubMed  CAS  Google Scholar 

  27. dePalbo P, Dietrich T, Karlson EW: Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample. Arthritis Rheum 2007, 57:953–962.

    Article  Google Scholar 

  28. Hahn BH, Grossman J, Chen W, McMahon M: The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemia. J Autoimmun 2007, 28:69–75.

    Article  PubMed  CAS  Google Scholar 

  29. Wasko MC, Hubert HB, Lilngala VB, et al.: Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA 2007, 298:187–193.

    Article  PubMed  CAS  Google Scholar 

  30. La Montagna G, Cacciapuoati F, Buono R, et al.: Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis. Diabetes Vasc Dis Res 2007, 4:130–135.

    Article  Google Scholar 

  31. Pamuk ON, Unlu E, Cakir N: Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis. J Rheumatol 2006, 33:2447–2452.

    PubMed  CAS  Google Scholar 

  32. Chung CP, Oeser A, Solus JF, et al.: Inflammation-associated insulin resistance: Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum 2008, 58:2105–2112.

    Article  PubMed  CAS  Google Scholar 

  33. Inaba M, Tanaka K, Goto H, et al.: Independent association of increased trunk fat with increased arterial stiffening in postmenopausal patients with rheumatoid arthritis. J Rheumatol 2007, 34:290–295.

    PubMed  Google Scholar 

  34. Giles JT, Ling SM, Ferrucci L, et al.: Abnormal body composition phenotypes in older rheumatoid arthritis patients: Association with disease characteristics and pharmacotherapies. Arthritis Rheum 2008, 59:807–815.

    Article  PubMed  Google Scholar 

  35. Mancuso CA, Rincon M, Sayles W, Paget SA: Comparison of energy expenditure from lifestyle physical activities between patients with rheumatoid arthritis and healthy controls. Arthritis Rheum 2007, 57:672–678.

    Article  PubMed  Google Scholar 

  36. Panoulas VF, Douglas KM, Milionis HJ, et al.: Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology 2007, 46:1477–1482.

    Article  PubMed  CAS  Google Scholar 

  37. Panoulas VF, Douglas KMJ, Stavropoulos-Kalinoglou A, et al.: Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. Rheumatology 2008, 47:72–75.

    Article  PubMed  CAS  Google Scholar 

  38. Davis JM, III, Kremers HM, Crowson CS, et al.: Glucocorticoids and cardiovascular events in rheumatoid arthritis. A population-based cohort study. Arthritis Rheum 2007, 56:820–830.

    Article  PubMed  CAS  Google Scholar 

  39. van Halm VP, Nurmohamed MT, Wtisk JW, et al.: Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis—a case control study. Arthritis Res Ther 2006, 8:R151–R156.

    Article  PubMed  Google Scholar 

  40. Wong M, Jiang BY, McNeil K, et al.: Effects of selective and non-selective cyclo-oxygenase inhibition on endothelial function in patients with rheumatoid arthritis. Scand J Rheumatol 2007, 36:265–269.

    Article  PubMed  CAS  Google Scholar 

  41. Listing J, Strangfeld A, Kekow J, et al.: Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis. Arthritis Rheum 2008, 58:667–677.

    Article  PubMed  CAS  Google Scholar 

  42. Solomon DH, Avorn J, Katz JN, et al.: Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 2006, 54:3790–3798.

    Article  PubMed  CAS  Google Scholar 

  43. Dixon WG, Watson KD, Lunt M, et al.: Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy. Arthritis Rheum 2007, 56:2905–2912.

    Article  PubMed  CAS  Google Scholar 

  44. Maki-Petaja KM, Hall FC, Booth AD, et al.: Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factoralpha therapy. Circulation 2006, 114:1185–1192.

    Article  PubMed  CAS  Google Scholar 

  45. Bilsborough W, Keen H, Taylor A, et al.: Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. Rheumatol Int 2006, 26:1125–1131.

    Article  PubMed  CAS  Google Scholar 

  46. Bosello S, Santoliquido A, Zoli A, et al.: TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. Clin Rheumatol 2008, 27:833–839.

    Article  PubMed  Google Scholar 

  47. Komai N, Morita Y, Sakuta T, et al.: Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol 2007, 17:385–390.

    Article  PubMed  CAS  Google Scholar 

  48. Ablin JN, Boguslavski V, Aloush V, et al.: Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci 2006, 79:2364–2369.

    Article  PubMed  CAS  Google Scholar 

  49. Seriolo B, Paolino S, Sulli A, et al.: Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis. Ann N Y Acad Sci 2006, 1069:414–419.

    Article  PubMed  CAS  Google Scholar 

  50. Popa C, van den Hoogen FH, Radstake RD, et al.: Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis. Ann Rheum Dis 2007, 66:1503–1507.

    Article  PubMed  CAS  Google Scholar 

  51. Kiortis DN, Mavridis AK, Vasakos S, et al.: Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum 2005, 64:765–766.

    Article  Google Scholar 

  52. Saiki O, Takao R, Naruse Y, et al.: In fliximab but not methotrexate induces extra-high levels of VLDL-Triglyceride in patients with rheumatoid arthritis. J Rheumatol 2007, 34:1997–2004.

    PubMed  CAS  Google Scholar 

  53. Motivala SJ, Khanna D, FitzGerald J, Irwin MR: Stress activation of cellular markers of inflammation in rheumatoid arthritis. Protective effects of tumor necrosis factor alpha antagonists. Arthritis Rheum 2008, 58:376–383.

    Article  PubMed  CAS  Google Scholar 

  54. Pahor A, Hojs R, Holc I, et al.: Antiphospholipid antibodies as a possible risk factor for atherosclerosis in patients with rheumatoid arthritis. Immunobiology 2006, 211:689–694.

    Article  PubMed  CAS  Google Scholar 

  55. Sherer Y, Gerli R, Gilburd B, et al.: Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies. Lupus 2007, 16:259–264.

    Article  PubMed  CAS  Google Scholar 

  56. Asanuma Y, Chung CP, Oeser A, et al.: Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis 2007, 195:e135–e141.

    Article  PubMed  CAS  Google Scholar 

  57. Daza L, Aguirre M, Jimenez M, et al.: Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. Clin Rheumatol 2007, 26:533–537.

    Article  PubMed  Google Scholar 

  58. Haruna Y, Morita Y, Yada T, et al.: Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis. Arthritis Rheum 2007, 56:1827–1835.

    Article  PubMed  CAS  Google Scholar 

  59. Maki-Petaja KM, Booth AD, Hall FC, et al.: Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 2007, 50:852–858.

    Article  PubMed  CAS  Google Scholar 

  60. Flammer AJ, Sudano I, Hermann F, et al.: Angiotensinconverting enzyme inhibition improves vascular function in rheumatoid arthritis. Circulation 2008, 117:2262–2269.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology and Clinical Immunology, University of Pittsburgh, BST South 704, 3500 Terrace Street, Pittsburgh, PA, 15261, USA

    Mary Chester M. Wasko

Authors
  1. Mary Chester M. Wasko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mary Chester M. Wasko.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wasko, M.C.M. Rheumatoid arthritis and cardiovascular disease. Curr Rheumatol Rep 10, 390–397 (2008). https://doi.org/10.1007/s11926-008-0063-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-008-0063-0

Keywords

Search

Navigation